For decades researchers have worked to find a way to orally administer insulin effectively to patients with diabetes. Now this game-changing treatment is one step closer to reality with pharmaceutical company Oramed embarking on a final Phase 2b human clinical trial to prove the efficacy of its oral insulin before moving to the final stages of trials and registrations that could bring the treatment to market within a few short years…
Continue Reading Oral insulin proving successful in human clinical trials
Cocoa compound has potential to combat diabetes
Protective packaging could hold the key to an effective insulin pill
Artificial pancreas learns your behavior and regulates insulin through a smartphone
Insulin releasing patch draws oral diabetes treatments closer
Insulin “capsules” may ultimately replace daily injections for diabetics
Are synthetic insulin-secreting cells the future of diabetes treatment?